Treatment considerations after initial diagnosis of dry syndrome: Dry syndrome is an immune system disorder. It is not scary, and in the early stages of diagnosis, it is recommended that organ function be assessed. If there is no organ involvement, interstitial lung involvement, renal tubular involvement or neurological involvement, the presence of biliary cirrhosis, etc., according to different situations, different treatment, but most patients are the mildest non-organ involvement, even if there is involvement, the disease can be controlled through active follow-up and treatment, the patient should have confidence. Treatment is as follows: The main measures are to improve symptoms, control and delay the progress of tissue and organ damage caused by immune response and secondary infection. 1.Improve symptoms It is more difficult to reduce dry mouth, should stop smoking, drinking and avoid taking drugs that cause dry mouth, such as atropine. Keep the mouth clean, rinse the mouth diligently to reduce the possibility of dental caries and oral secondary infection. Domestic cyclopentathione to improve the symptoms of dry mouth. 2, dry keratoconjunctivitis can be given artificial tears drops to reduce dry eye symptoms and prevent corneal damage. Beijing Hospital’s sodium vitrate eye drops, carboxymethyl cellulose eye drops can improve the symptoms, if necessary, can be done to close the tear point. 3, muscle, joint pain can be used non-steroidal anti-inflammatory drugs as well as hydroxychloroquine. Hypokalemia: To correct the paralytic attack of hypokalemia, intravenous potassium supplementation (potassium chloride) can be used, and after the condition is stabilized, oral potassium salts or tablets can be used, and some patients need to take it for life to prevent hypokalemia from occurring again. Most patients can still live and work normally after correction of hypokalemia. Patients with systemic damage should be treated accordingly with respect to the damaged organs and their severity. Adrenocorticotropic hormone should be given in the same dose as for other connective tissue diseases if there is a combination of neurological, glomerulonephritis, interstitial lung disease, liver damage, hypokalemia, especially low platelet count, and myositis. Immunosuppressants such as cyclophosphamide and azathioprine can be used in combination for rapid progression of the disease. Those with malignant lymphoma should be treated with combination chemotherapy in an aggressive and timely manner. Prognosis: The prognosis of this disease is good, most of the patients with visceral damage can control the disease to achieve remission after appropriate treatment, but the disease can recur again after stopping treatment. The prognosis is worse for those with progressive pulmonary fibrosis, central neuropathy, glomerular damage with renal insufficiency, and malignant lymphoma, while most of the remaining systemic damages can be relieved after appropriate treatment, and even return to daily life and work.